Neural Pharm

Neural Pharm

Share this post

Neural Pharm
Neural Pharm
FDA Denies MDMA-Assisted therapy

FDA Denies MDMA-Assisted therapy

What went wrong and what does it mean going forward for other drugs in clinical trials? Plus, a bit about politics, and the FDA approves Neffy for anaphylaxis

Dr. Colby Burns, PharmD's avatar
Dr. Colby Burns, PharmD
Aug 26, 2024
∙ Paid
1

Share this post

Neural Pharm
Neural Pharm
FDA Denies MDMA-Assisted therapy
1
Share

Photo credit: Shutterstock

Hello and welcome back readers. It’s been a long time since we posted an article. We recently posted our first podcast in several months—catch up here if you missed it.

Yes, a lot has changed since we recorded that podcast in July. President Joe Biden officially dropped out of the race following his disastrous June debate perf…

Keep reading with a 7-day free trial

Subscribe to Neural Pharm to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Colby
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share